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Abstract
Background: The Global Physical Activity Questionnaire (GPAQ) has been used to measure physical activity (PA) and sedentary time in France,
but no study has assessed its psychometric properties. This study aimed to compare the reliability as well as criterion and concurrent validity of
the French version of the GPAQ with the French International PA Questionnaire long form (IPAQ-LF) and use of an accelerometer in a general
adult population.
Methods: We included 92 participants (students or staff) from the Medicine Campus at the University of Lorraine, Nancy (north-eastern France). The
French GPAQ was completed twice, 7 days apart, to study test-retest reliability. The IPAQ-LF was used to assess concurrent validity of the GPAQ, and
participants wore an accelerometer (Actigraph GT3X+) for 7 days to study criterion validity. Reliability as well as concurrent and criterion validity
of the GPAQ were tested by the intraclass correlation coefficient (ICC), Spearman correlation coefficient for quantitative variables, and Kappa and Phi
coefficients for qualitative variables. Both concurrent and criterion validity of GPAQ were assessed by Bland-Altman plots.
Results: The GPAQ showed poor to good reliability (ICC = 0.37–0.94; Kappa = 0.50–0.62) and concurrent validity (Spearman r = 0.41–0.86), but
only poor criterion validity (Spearman r = 0.22–0.42). Limits of agreement for the GPAQ and accelerometer were wide, with differences between
286.5 min/day and 601.3 min/day.
Conclusion: The French version of the GPAQ provides limited but acceptable reliability and validity for the measurement of PA and sedentary
time. It may be used for assessing PA and sedentary time in a French adult population.
© 2016 Production and hosting by Elsevier B.V. on behalf of Shanghai University of Sport. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Physical activity (PA) surveillance is a public health preoc-
cupation and is considered by the World Health Organisation
(WHO) as a protective factor for non-communicable diseases.1
A high PA level is associated with reduced mortality and the
occurrence of diseases or their consequences and improved
quality of life.2,3 Because of its therapeutic role, PA is also used
as adjuvant treatment in chronic diseases.4,5
In this context, the measurement of PA is essential to assess
strategies promoting PA and to survey and compare PA levels
between countries. Questionnaires are the most commonly used
instrument in epidemiologic studies to assess PA because they
are relatively inexpensive and easy to use both for a large
population and in a short time. They can be self-administered,
completed during an interview or administered by phone. Many
different questionnaires have been developed and used to
measure PA, so international comparison is difficult, and
overall, their development lacked methodological quality.6
In the late 1990s, the International Physical Activity Ques-
tionnaire (IPAQ) was developed in 2 forms (short form (IPAQ-
SF) and long form (IPAQ-LF)) to create national and
international comparable and standardized measures of PA. The
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long form of the IPAQ (31 items) was developed to capture
information about domains of PA but has been considered too
long and too complex to be used in surveillance studies, while
the short form (9 items) does not take into account the domains
of PA.7,8 For PA surveillance, the measurement of PA domains
is needed to understand the patterns of PA and to develop
interventions. Thus, in order to provide an instrument that
would address the limits of these questionnaires, the Global
Physical Activity Questionnaire (GPAQ) has been developed by
the WHO, as part of the WHO STEPwise approach to survey
chronic disease risk factors. It is now recommended by the
WHO for national surveillance of PA.1 Since its development,
the GPAQ has been translated into and tested in many languages
and is used in many countries.9-16 In France, the GPAQ has been
used to describe and analyse PA and sedentary time of the
general population.17 However, it has not been validated in the
French language. Evidence for the validity and reliability of the
French version of the GPAQ is needed because the results may
be affected by the sociocultural specificities of the country.18
Rigorous methodology is needed to examine the degree in
which an instrument is affected by measurement error (reliabil-
ity) and measures the construct it intends to measure
(validity).19 Concurrent validity refers to the degree to which
the GPAQ measures what it purports to measure, and criterion
validity is the degree to which the results of the questionnaire
are an adequate reflection of a “gold standard”. Because of no
satisfying available gold standard measurement for PA behav-
ior, objective measures such as accelerometers and pedometers
are commonly used. To appraise the concurrent validity of the
GPAQ, a questionnaire measuring the same construct and with
similar structure is considered relevant. Even if the IPAQ-LF is
more detailed than the GPAQ, it is the most similar in its
construct and its structure. For this reason, the IPAQ-LF has
been considered relevant to examine the concurrent validity of
the GPAQ.
This study aimed to assess the test-retest reliability as well as
criterion and concurrent validity of the French version of the
GPAQ by comparison with the IPAQ-LF and use of an acceler-
ometer in a general adult population in France.
2. Methods
2.1. Patients and study design
A convenient sample was recruited from January 20, 2015 to
April 20, 2015, from the Medicine Campus, University of Lor-
raine, Nancy (north-eastern France), by posting an advertise-
ment on campus and by e-mailing students and staff.
Participants had to be ≥18 years old, working or studying at the
Medicine Campus, able to read and understand French, and
willing to participate in the study. The study protocol was
approved by the Legal representative of the French data protec-
tion authority (Commission Nationale Informatique et
Libertés) of the University of Lorraine, France. All participants
were asked to read and sign a consent form. A ratio of 5 subjects
per item was used to determine the number of participants to
include.20 Because the GPAQ contained 16 items, a minimum
number of 80 participants was required.
Each subject was invited to participate in a face-to-face
interview on Day 0 (D0) and receive all explanations about the
study and its purpose from an interviewer. After giving consent,
participants answered sociodemographic and anthropometric
questions, then completed the GPAQ and IPAQ-LF. Then, the
interviewer gave the participant an accelerometer and explained
its use. Participants were asked to wear the accelerometer for 7
consecutive days. Eight days after the first interview (D8),
participants returned the accelerometer and completed the
GPAQ and IPAQ-LF a second time. They were also asked if they
had changed their activity during the week of the study as
compared to a typical week.
2.2. Instruments
We used the French translation of the GPAQ (Version 2.0)21
to gather information on the time spent in moderate and vigor-
ous PA and in sedentary behavior. At the WHO level, the GPAQ
has been translated in French by a professional translator, and
back-translated by 2 independent technical experts. The ver-
sions were then compared, and where discrepancies existed,
these were discussed and a consensus was found. The GPAQ
contains 16 items designed to assess the frequency and duration
of PA in 3 domains: during work, transportation, and leisure
time as well as time spent sitting during a typical week. It
distinguishes PA duration by min/day and min/week for each
PA domain, which allows for calculating the energy expenditure
scored in metabolic equivalent tasks (METs). One MET corre-
sponds to resting energy expenditure. According to duration
and energy expenditure, PA level was classified as low, moder-
ate, and high.
The French IPAQ-LF was used to test the concurrent validity
of the GPAQ. It contains 27 items designed to assess the fre-
quency and duration of PA in 4 domains: during work, trans-
portation, household activities, and leisure time, then time spent
sitting.22 The IPAQ-LF scores PA in terms of energy expendi-
ture (MET), intensity (low, moderate, high, and sedentary), and
duration (min/day, min/week).
The ActiGraph accelerometer, model GT3X+ (ActiGraph,
Pensacola, FL, USA), was used as the criterion measure. The
device is worn at the waist and measures and records the changes
in acceleration and deceleration movements in 3 axes (antero-
posterior, superio-inferior, and medial side). Data for measuring
acceleration and deceleration are stored in non-volatile flash
memory and can be read by using ActiLife software. Acceler-
ometer data were scored using ActiLife 6 Data Analysis Soft-
ware (ActiGraph) to assess time spent at various PA intensity
levels (moderate and vigorous in min/day). Freedson’s Adult
VM3 (2011) cut-off points were used to determine several PA
levels: light, 0–2690 counts per minute (CPM); moderate, 2691–
6166 CPM; vigorous, 6167–9642 CPM; and very vigorous,
9643–∞ CPM. Minutes spent at each intensity level were aver-
aged across valid days. Non-wear periods were identified as 60
consecutive minutes with no movement data o (0 counts).23 All
calculations were based on 60 s epochs; an epoch is a user-
defined time-sampling interval used to filter the acceleration
signal. In this study, we used 7-days PA questionnaires, so only
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data with ≥10 h of wear time per day for ≥7 days were considered
valid and included in the analysis.24,25
Sociodemographic data such as age, sex, and education
(high school or higher education) and socioprofessional status
(student or staff) were collected. Anthropometric data including
height (in cm) and weight (in kg) were reported by each par-
ticipant for calculating body mass index (BMI, kg/cm2), then
participants were classified by BMI level: underweight (BMI
<18.5 kg/cm2), normal weight (18.5–24.9 kg/cm2), overweight
25.0–29.9 kg/cm2), and obese (>30 kg/cm2). All data (except
accelerometer data directly transferred into ActiLife software)
were entered into an electronic case report form (CRF) created
with Epidata 3.1 (The EpiData Association, Odense, Denmark).
2.3. Statistical analysis
Data analysis involved use of SAS 9.4 (SAS Inst., Cary, NC,
USA). Qualitative variables were reported as relative frequency
and quantitative variables as mean ± SD or median. The
Kolmogorov-Smirnov test was used to assess the normality of
data distribution. For participants who declared changing their
PA, paired Student’s t test was used to evaluate the difference in
total PA between the 2 visits. Because the activity measured by
the GPAQ includes work and household activities, it was com-
pared to the sum of work and household PA measured by the
IPAQ-LF.
Test–retest reliability was tested by the kappa coefficient for
categorical data and the intraclass correlation coefficient (ICC)
for quantitative data. Spearman correlation was also calculated
for quantitative data to compare with previous studies.11-14 Non
parametric correlation coefficient was used because of non-
Gaussian distribution for most of PA-score. For one of the
GPAQ’s question, one answer modality was overrepresented
and the correlation was not concordant with the observed
agreement (when visualizing the data, the agreement seems
good but it was not observed when assessed with ICC and
Spearman correlation). Thus the variable was converted into a
discrete variable, and the prevalence-adjusted and bias-adjusted
kappa (PABAK) was used to assess the agreement.26 Concur-
rent validity was examined by comparing data for the GPAQ
and IPAQ-LF at D0 and D819 with the Spearman correlation
coefficient and its 95%CI for quantitative data and the Phi
coefficient for qualitative data. Criterion validity was examined
by comparing minutes of PA obtained with the GPAQ to
accelerometer-obtained data at D8 by the Spearman correlation
coefficient and its 95%CI.
Both the concurrent and criterion validity of the GPAQ were
assessed by Bland-Altman plots to measure the agreement and
bias for total PA and sedentary time between questionnaire’s
answers and results from accelerometer.27 Correlation assesses
the degree to which 2 variables are related. However, a high
correlation does not necessary imply that there is good agree-
ment between the 2 methods. Thus, Bland-Altman was used to
quantify the agreement between 2 measurements by plotting the
difference between the 2 measurements against the average
obtained with each of the 2 methods.
Kappa and Phi coefficients were classified by the ratings
suggested by Landis and Koch:28 poor, <0.00; slight, 0.00–0.20;
fair, 0.21–0.40; moderate, 0.41–0.60; substantial, 0.61–0.80;
and almost perfect, 0.81–1.00. ICC and Spearman correlation
<0.50 were considered as poor, between 0.50 and 0.75 as mod-
erate, and >0.75 were as good.29
3. Results
3.1. Participant characteristics
In total, 92 subjects participated in the study (mean age
30.1 ± 10.7 years, range 19–58 years; 67 (72.8%) females);
56.5% were students, 95.6% had higher education, 9.8% had
chronic disease, and 76.9% had normal BMI (Table 1). Overall,
25% of participants declared having changed their activity
between the 2 visits, but the difference between the total PA
means measured by the GPAQ was not statistically significant
(p = 0.49).
3.2. Descriptive statistics for the GPAQ, IPAQ, and
accelerometer
All descriptive statistics for GPAQ, IPAQ, and accelerometer
are presented in Table 2.
3.3. Test-retest reliability
The ICCs ranged from 0.37 to 0.94, with the highest ICC for
vigorous leisure PA. Only total vigorous and vigorous leisure PA
showed good reliability, whereas all other PA scores were poor to
moderate, with the lowest value for moderate leisure
PA(ICC = 0.37, 95%CI: 0.15–0.56). A good reliability for total
sitting time was also observed (ICC = 0.80, 95%CI: 0.69–0.87)
whereas it was moderate for total PA (ICC = 0.58, 95%CI: 0.40–
0.72). For PA level, the kappa coefficient showed moderate to
substantial correlation, varying from 0.50 to 0.62 for moderate
and low PA levels, respectively. For vigorous activity at work, the
GPAQ showed an almost perfect reliability (PABAK = 0.91).
Except for total PA, with ICC = 0.58, 95%CI: 0.40–0.72 and
Spearman’s r = 0.82, 95%CI: 0.72–0.88, most Spearman values
were similar to the ICC (Table 3).
Table 1
Sociodemographic and anthropometric characteristics of participants.
Total sample (n = 92, %)
Sex
Male 25 (27.7)
Female 67 (72.8)
Socio-professional status
Student 52 (56.5)
Staff 40 (43.5)
Education level
High school 4 (4.4)
Higher education 88 (95.6)
Age (year)* 30.1 ± 10.7
BMI (kg/cm2)*
BMI classes (kg/cm2)*
22.6 ± 3.5
Underweight <18.5 3 (3.3)
Acceptable weight 18.5-24.9 71 (76.9)
Overweight 25.0–29.9 14 (15.4)
Obese >30 4 (4.4)
* Data are presented as mean ± SD.
Abbreviation: BMI = body mass index.
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3.4. Concurrent validity
For both measurement times, we observed good correlations
between the GPAQ and IPAQ for vigorous activity during
leisure, total vigorous activity, and sitting time (r = 0.76–0.89)
(Table 4). The values at D0 and D8 seemed almost identical, but
important discrepancies were observed between vigorous work
at D0 (r = 0.58, 95%CI: 0.43–0.70) and at D8 (r = 0.81,
95%CI: 0.73–0.87). Overall, total PA showed moderate
Table 2
Data for PA measured by the Global Physical Activity Questionnaire GPAQ, IPAQ and an accelerometer at day 0 (D0) and day 8 (D8) in 92 participants.
Variable GPAQ IPAQ Accelerometer
D0 D8 D0 D8
Mean ± SD Median Mean ± SD Median Mean ± SD Median Mean ± SD Median Mean ± SD Median
Total PA (MET min/week) 2011.1 ± 1940.5 1580.0 1818.0 ± 1478.2 40.7 2648.3 ± 2099.8 2251.5 2484.1 ± 2268.0 1777.5
PA by domain
Work
Vigorous 31.3 ± 300.3 0 33.0 ± 230.6 0 34.8 ± 300.8 0 15.6 ± 85.7 0
Moderate 467.4 ± 1575.3 0 321.1 ± 965.4 0 203.5 ± 758.1 0 212.4 ± 871.2 0
Transport 375.9 ± 410.8 240.0 378.5 ± 426.2 250.0 306.8 ± 295.5 242.5 351.3 ± 414.0 260.7
Household
Vigorous n/a n/a n/a n/a 4.5 ± 35.4 0 22.1 ± 126.1 0
Moderate n/a n/a n/a n/a 475.9 ± 785.2 150.0 356.7 ± 594.3 160.0
Work + household
Vigorous n/a n/a n/a n/a 39.3 ± 302.4 0 37.8 ± 171.8 0
Moderate n/a n/a n/a n/a 695.0 ± 1080.1 240.0 596.1 ± 1189.1 190.0
Leisure
Vigorous 852.2 ± 1073.3 680.0 772.6 ± 955.9 480.0 868.7 ± 1085.9 600.0 691.3 ± 1011.5 0
Moderate 284.3 ± 366.0 240.0 312.8 ± 382.9 240.0 193.9 ± 265.4 0 218.9 ± 415.4 340.0
Sitting time (min/day) 570.0 ± 152.8 600.0 588.6 ± 146.4 600.0 554.5 ± 138.5 584.3 583.6 ± 143.2 597.1 843.6 ± 134.5 814.0
PA duration by intensity
(min/week)
Vigorous 883.5 ± 1090.1 720.0 805.6 ± 977.7 480.0 903.5 ± 1102.4 720.0 707.0 ± 1015.6 360.0 72.0 ± 67.2 46.7
Moderate 751.7 ± 1659.8 360.0 633.9 ± 990.3 360.0 903.8 ± 1131.4 480.0 860.6 ± 1266.9 370.0 426.2 ± 139.5 429.4
PA level (%)
Low 29.4 22.8 8.7 15.2
Moderate 44.6 45.6 60.9 54.3
High 26.1 22.8 30.4 30.4
Abbreviation: GPAQ = global physical activity questionnaire; IPAQ = international physical activity questionnaire; MET = metabolic equivalent task; n/a = not
assessed by the questionnaire; PA = physical activity.
Table 3
Test-retest reliability of the GPAQ (n = 68).
Variables ICC
(95%CI)
Spearman’s Rho
(95%CI)
Kappa
coefficient
Total PA 0.58 (0.40–0.72) 0.82 (0.72–0.88)
PA by domain
Work
Vigorous 0.91(+)
Moderate 0.48 (0.28–0.64) 0.52 (0.33–0.68)
Transport 0.67 (0.52–0.79) 0.69 (0.53–0.79)
Leisure
Vigorous 0.94 (0.91–0.96) 0.89 (0.84–0.94)
Moderate 0.37 (0.15–0.56) 0.53 (0.33–0.68)
Sitting time 0.80 (0.69–0.87) 0.78 (0.67–0.86)
PA by intensity
Total vigorous 0.84 (0.76–0.90) 0.80 (0.70–0.88)
Total moderate 0.48 (0.28–0.65) 0.56 (0.38–0.71)
PA level
Low 0.62
Moderate 0.50
High 0.57
(+): Adjusted kappa (PABAK).
Abbreviations: GPAQ = global physical activity questionnaire; PA = physical
activity; ICC = intraclass correlation coefficient; 95%CI = 95% confidence
interval.
Table 4
Concurrent validity between the GPAQ and IPAQ-LF data at day 0 (D0) and day
8 (D8) (n = 92).
Variable D0 D8
Spearman’s
Rho (95%CI)
Phi
coefficient
Spearman’s
Rho (95%CI)
Phi
coefficient
Total PA 0.66 (0.53–0.76) 0.67 ((0.54–0.77)
PA by domain
Work
Vigorous 0.58 (0.43–0.70) 0.81 (0.73–0.87)
Moderate 0.56 (0.40–0.68) 0.61 (0.46–0.72)
Transport 0.52 (0.35–0.65) 0.69 (0.57–0.79)
Leisure
Vigorous 0.86 (0.79–0.90) 0.79 (0.70–0.85)
Moderate 0.46 (0.28–0.61) 0.53 (0.36–0.66)
Sitting time 0.85 (0.78–0.90) 0.89 (0.84–0.93)
PA by intensity
Total vigorous 0.86 (0.79–0.90) 0.76 (0.66–0.84)
Total moderate 0.41 (0.22–0.56) 0.58 (0.42–0.70)
PA level
Low 0.22 0.49
Moderate 0.27 0.27
High 0.57 0.54
Abbreviations: GPAQ = global physical activity questionnaire; IPAQ-LF =
international physical activity questionnaire-long form; PA = physical activity.
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correlation at both D0 (r = 0.66, 95%CI: 0.53–0.76) and D8
(r = 0.67, 95%CI: 0.54–0.77). Results of Bland-Altman analy-
sis (Fig. 1A, C) for the GPAQ and IPAQ demonstrated a mean
difference of 637.2 ± 1641.5 MET min/week. The limits of
agreement for the 2 instruments were wide, with the
difference between 1004.3 and 2580.1. For sedentary time, the
mean difference of sedentary time was −15.5 ± 79.2 min/day.
Overall, the classification by level of PA with the 2 question-
naires, at both times, was only poorly to moderately correlated,
with a Phi coefficient ranged from 0.22 to 0.57.
3.5. Criterion validity
Accelerometer data were considered valid for 87 of the 92
participants (5 participants did not wear an accelerometer for at
least 10 h per day over 7 days). Criterion validity was assessed
by comparing total PA time spent in vigorous-intensity activity,
or in moderate-intensity activity, or sitting per day reported with
the GPAQ and derived from accelerometer counts. Poor but
significant correlations for sedentary time (r = 0.42, p < 0.01)
and total vigorous PA (r = 0.38, p < 0.01) were observed
(Table 5).
Bland-Altman findings revealed that the GPAQ underreported
total PA, with a mean difference between the GPAQ and acceler-
ometer data of 443.95 ± 157.46 min/week (Fig. 1B, D). Limits of
agreement for the 2 instruments were wide, with the difference
between 286.5 and 601.3 min/week GPAQ underestimated seden-
tary time as compared with the accelerometer, with a mean
difference between the 2 instruments of 251.2 ± 161.1 min/day.
Limits of agreement for the 2 instruments ranged from 90.1 to
412.3 min/day.
4. Discussion
This study provides results, for the first time in a French
population, for the reliability and validity of the GPAQ.
Fig. 1. Bland-Altman plots of the validity of the Global Physical Activity Questionnaire (GPAQ). A&C: Agreement of GPAQ with IPAQ for total PA(A), sitting time
(B) at D0; B&D: Agreement of GPAQ with accelerometer for total PA (C), sitting time (D) at D8. IPAQ = international physical activity questionnaire; PA = physical
activity.
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For reliability, we found poor to good correlation, with
highest value obtained for vigorous leisure PA, which indicates
the stability of this type of PA. This result is consistent with the
findings by Matthews et al.30 who observed no significant varia-
tion in vigorous leisure time activity over 1 year in 580 healthy
adults.30 Overall, our results are comparable to other studies
testing the psychometric properties of the GPAQ. Herrmann et
al.13 demonstrated short- and long-term reliability with ICC
values from 0.54 to 0.92. Bull et al.11 reported test–retest cor-
relation coefficients from 0.67 to 0.81 and kappa coefficients
from 0.67 to 0.73 for pooled data.
Whereas Bull et al.11 and Herrmann et al.13 showed a poor to
moderate correlation between the GPAQ and IPAQ (with coef-
ficients from 0.45 to 0.57 and 0.26 to 0.63, respectively), our
results indicate a poor to good concurrent validity. A reason of
this difference could be the use, by the former studies, of the
IPAQ short-form (IPAQ-SF) as compared with our use of the
long form. Unlike the GPAQ and IPAQ-LF, which measure PA
in different domains, the IPAQ-SF measures overall PA duration
and frequency, which may explain the differences. In measuring
the concurrent validity of the GPAQ, the IPAQ-LF may be more
relevant than the IPAQ-SF. However, despite an acceptable con-
current validity, the agreement between the GPAQ and the
IPAQ-LF to classify participants by PA levels was only poor to
moderate (Phi coefficients 0.22 to 0.57), with the highest agree-
ment attributable to high PA level. In addition, the Bland-
Altman analysis revealed wide discrepancies in total PA
measured by the 2 questionnaires, with a mean difference of
637.2 ± 1641.5 MET min/week. A possible explanation could
be that the IPAQ-LF contains detailed items dedicated to house-
hold activities, whereas in the GPAQ, household activities are
included in work activities. Also, the IPAQ-LF measures time
spent walking, which is not considered by the GPAQ if it is not
brisk walking (considered moderate activity). These differences
may explain the gap in total PA measured by the 2 question-
naires. These results indicate the difficulty in comparing differ-
ent questionnaires and thus the need to use the same
questionnaire in a population surveillance study to be able to
interpret the pattern of PA over the years.
A poor criterion-related validity for the GPAQ as compared
with accelerometer data was shown. These results are compa-
rable to Cleland et al.12 and Bull et al.,11 who demonstrated
correlations with accelerometer data ranging from 0.19 to 0.48
and −0.20 to 0.40, respectively, whereas results from Hoos et
al.14 showed correlations from 0.32 to 0.52. According to
Bland-Altman analysis, the GPAQ seems to underestimate total
PA as compared with the accelerometer. This finding can be
explained by the GPAQ including only PA that lasts at least
10 min, whereas the accelerometer measures all activities
regardless of duration. This result was already found in studies
comparing questionnaires to objective measures of PA.31 In this
study and according to Bland-Altman analysis, the GPAQ
seemed to underestimate sedentary time as measured by the
accelerometer. This finding can be justified most likely by dif-
ficulty to accurately recall sitting time as well as by a response
bias due to social desirability, which may affect the degree of
reporting the time spent sitting by subjects.31 Future research is
needed to identify whether a bias does exist and if so, whether
it differs by gender or socioprofessional status, and to what
extent.
This study had several strengths, beginning with the adher-
ence to standardized WHO protocols in administering question-
naires (GPAQ was always administered before the IPAQ) and
the concordant measurement period (the same 7 days) for both
questionnaires and the accelerometer. Also, we used Bland-
Altman analysis, a useful and recommended approach to assess
the level of agreement, as compared with usual correlation
coefficients assessing only the strength of the relationship
between the measures.27 Finally, the use of the IPAQ-LF seems
relevant because it induced better concurrent validity with the
GPAQ than in previous studies.
The major limitation of this study was the use of accelerom-
eter as an alternative to the gold standard. However, in the
absence of a gold standard, accelerometer may be used to
measure PA in daily life.32,33
5. Conclusion
This study adds important and new information in testing the
psychometric properties of the GPAQ in France. The results
suggest that the GPAQ is a reliable questionnaire for use in the
French population. The overall validity was poor to good but
remained acceptable and was similar to previous studies.11,12
Another important highlight is the need to use the same ques-
tionnaire in surveillance studies to allow for comparison and
follow-up of the PA level of the study population and for PA
surveillance in general.
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